Tianjin Tianyao Pharmaceuticals Co., Ltd. Class ASSE: 600488

Announcement on Subsidiary Passing the US FDA's Routine On-Site CGMP Inspection

· Issued by Tianjin Tianyao Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Subsidiary Passing the US FDA's Routine On-Site CGMP Inspection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis